Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patient-reported burden of myasthenia gravis: baseline results of the international prospective, observational, longitudinal real-world digital study MyRealWorld-MG.
Dewilde S, Philips G, Paci S, Beauchamp J, Chiroli S, Quinn C, Day L, Larkin M, Palace J, Berrih-Aknin S, Claeys KG, Muppidi S, Mantegazza R, Saccà F, Meisel A, Bassez G, Murai H, Janssen MF. Dewilde S, et al. Among authors: beauchamp j. BMJ Open. 2023 Jan 31;13(1):e066445. doi: 10.1136/bmjopen-2022-066445. BMJ Open. 2023. PMID: 36720569 Free PMC article.
Patient-reported impact of myasthenia gravis in the real world: findings from a digital observational survey-based study (MyRealWorld MG).
Berrih-Aknin S, Palace J, Meisel A, Claeys KG, Muppidi S, Saccà F, Amini F, Larkin M, Quinn C, Beauchamp J, Philips G, De Ruyck F, Ramirez J, Paci S. Berrih-Aknin S, et al. Among authors: beauchamp j. BMJ Open. 2023 May 11;13(5):e068104. doi: 10.1136/bmjopen-2022-068104. BMJ Open. 2023. PMID: 37169499 Free PMC article.
Subcutaneous efgartigimod PH20 in generalized myasthenia gravis: A phase 3 randomized noninferiority study (ADAPT-SC) and interim analyses of a long-term open-label extension study (ADAPT-SC+).
Howard JF Jr, Vu T, Li G, Korobko D, Smilowski M, Liu L, Gistelinck F, Steeland S, Noukens J, Van Hoorick B, Podhorna J, Borgions F, Li Y, Utsugisawa K, Wiendl H, De Bleecker JL, Mantegazza R; ADAPT-SC and ADAPT-SC+ Study Groups. Howard JF Jr, et al. Neurotherapeutics. 2024 Sep;21(5):e00378. doi: 10.1016/j.neurot.2024.e00378. Epub 2024 Sep 2. Neurotherapeutics. 2024. PMID: 39227284 Free article. Clinical Trial.
Development of an Acute Stroke Care Seeking Framework.
Smith FS, Whisenant M, Johnson CM, Burnett J, Savitz SI, Beauchamp JES. Smith FS, et al. Among authors: beauchamp jes. J Neurosci Nurs. 2024 Dec 1;56(6):250-255. doi: 10.1097/JNN.0000000000000782. Epub 2024 Aug 9. J Neurosci Nurs. 2024. PMID: 39133535 Review.
Genetic Variation and Stroke Recovery: The STRONG Study.
Cramer SC, Parodi L, Moslemi Z, Braun RG, Aldridge CM, Shahbaba B, Rosand J, Holman EA; STRONG Study Investigators. Cramer SC, et al. Stroke. 2024 Aug;55(8):2094-2102. doi: 10.1161/STROKEAHA.124.047643. Epub 2024 Jul 9. Stroke. 2024. PMID: 38979623
306 results